SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
International review of blood donation nucleic acid amplification testing
8 references·3 citing·32 second hop
International review of blood donation nucleic acid amplification testing (2024)International review of blood donation nu…HIV, HCV, and HBV incidence and residual risk in US blood donors before and after implementation of the 12‐month deferral policy for men who have sex with men (2021)HIV, HCV, and HBV incidence a…HIV incidence in US first-time blood donors and transfusion risk with a 12-month deferral for men who have sex with men (2020)HIV incidence in US first-tim…Prevention of transfusion-transmitted infections (2019)Prevention of transfusion-tra…International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009 (2011)International survey on NAT t…A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors (2005)A new strategy for estimating…Mathematic modeling of the risk of HBV, HCV, and HIV transmission by window‐phase donations not detected by NAT (2002)Mathematic modeling of the ri…Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology (2002)Implementation of donor scree…The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection (1997)The incidence/window period m…Incidence and window period residual risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus in United States blood donations, 2017 to 2023: The transfusion‐transmissible infections monitoring system (2025)Incidence and window period r…International review of blood donation screening for anti‐HBc and occult hepatitis B virus infection (2024)International review of blood…An international review of the characteristics of viral nucleic acid‐amplification testing (NAT) reveals a trend towards the use of smaller pool sizes and individual donation NAT (2024)An international review of th…Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting (1999)Comparative analysis of triplex nucleic acid test assays in United States blood donors (2013)History and Future of Nucleic Acid Amplification Technology Blood Donor Testing (2019)The Risk of Transfusion-Transmitted Viral Infections (1996)Human immunodeficiency virus, hepatitis C and hepatitis B infections among blood donors in Germany 2000-2002: risk of virus transmission and the impact of nucleic acid amplification testing (2005)Assessing the impact of HBV NAT on window period reduction and residual risk (2006)Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6‐year survey (2008)Transmission of Human Immunodeficiency Virus (HIV) by Blood Transfusions Screened as Negative for HIV Antibody (1988)Exposure of Patients to Human Immunodeficiency Virus through the Transfusion of Blood Components That Test Antibody-Negative (1989)Evaluation of Screened Blood Donations for Human Immunodeficiency Virus Type 1 Infection by Culture and DNA Amplification of Pooled Cells (1991)International application of the Incidence Rate/Window Period model (2002)Cost‐effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States (2004)Current incidence and estimated residual risk of transfusion‐transmitted infections in donations made to Canadian Blood Services (2007)Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population (2002)Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing (2004)Transfusion-transmitted infections (2007)Donor Testing and Risk: Current Prevalence, Incidence, and Residual Risk of Transfusion-Transmissible Agents in US Allogeneic Donations (2011)Health and healthcare disparities among U.S. women and men at the intersection of sexual orientation and race/ethnicity: a nationally representative cross-sectional study (2017)An international comparison of HIV prevalence and incidence in blood donors and general population: a BEST Collaborative study (2021)HIV risk behavior profiles among men who have sex with men interested in donating blood: Findings from the Assessing Donor Variability and New Concepts in Eligibility study (2023)Leveraging Donor Populations to Study the Epidemiology and Pathogenesis of Transfusion-Transmitted and Emerging Infectious Diseases (2023)Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing (2010)Refinement of a viral transmission risk model for blood donations in seroconversion window phase screened by nucleic acid testing in different pool sizes and repeat test algorithms (2010)HIV incidence and compliance with deferral criteria over three progressively shorter time deferrals for men who have sex with men in Canada (2021)HIV incidence and related risks among gay, bisexual, and other men who have sex with men in Montreal, Toronto, and Vancouver: Informing blood donor selection criteria in Canada (2022)Hepatitis B virus testing by minipool nucleic acid testing: does it improve blood safety? (2013)Nucleic acid amplification technology methods used in blood donor screening (2002)Health and economic impact of posttransfusion hepatitis B and cost‐effectiveness analysis of expanded HBV testing protocols of blood donors: a study focused on the European Union (2003)Automated nucleic acid amplification testing in blood banks: An additional layer of blood safety (2015)Guidance for the procurement of COVID‐19 convalescent plasma: differences between high‐ and low‐middle‐income countries (2020)HIV antiretroviral therapy and prevention use in US blood donors: a new blood safety concern (2020)Assessing the global burden of hemorrhage: The global blood supply, deficits, and potential solutions (2021)
this work references cited by second hop

References

  • 2005A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors426 cited
  • 2019Prevention of transfusion-transmitted infections295 cited
  • 2011International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009191 cited
  • 1997The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection168 cited
  • 2002Mathematic modeling of the risk of HBV, HCV, and HIV transmission by window‐phase donations not detected by NAT117 cited
  • 2021HIV, HCV, and HBV incidence and residual risk in US blood donors before and after implementation of the 12‐month deferral policy for men who have sex with men52 cited
  • 2002Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology38 cited
  • 2020HIV incidence in US first-time blood donors and transfusion risk with a 12-month deferral for men who have sex with men34 cited

Cited by

  • 2024International review of blood donation screening for anti‐HBc and occult hepatitis B virus infection23 cited
  • 2025Incidence and window period residual risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus in United States blood donations, 2017 to 2023: The transfusion‐transmissible infections monitoring system6 cited
  • 2024An international review of the characteristics of viral nucleic acid‐amplification testing (NAT) reveals a trend towards the use of smaller pool sizes and individual donation NAT6 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work